PRECISIONCYP
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

PRECISIONCYP Trademark

Serial Number: 99666060

PRECISIONCYP is a trademark filed by Laboratory Corporation of America Holdings on February 23, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Laboratory Corporation of America Holdings (6 trademarks)

531 South Spring Street
Burlington, NC 27215

Entity Type: 03

Trademark Details

Filing Date

February 23, 2026

Registration Date

Not Registered

Goods & Services

Diagnostic kits for medical purposes comprising diagnostic agents, preparations and substances for medical use; Medical diagnostic assays for detecting the presence of genotypes for medical purposes; diagnostic kits for medical use comprised of medical diagnostic reagents and assays for testing for genotypes

Genotyping services for research or analysis purposes

Assays for research purposes, namely, chemical reagents for laboratory use; assays for clinical or medical laboratory use, namely, diagnostic reagents for laboratory use; assays for detecting genotypes in clinical trials and pharmaceutical research for research purposes, namely, reagents for testing how a person metabolizes and responds to medication; assays for detecting genotypes for research purposes in the fields of pharmaceutical testing, biotechnology, medical research, and clinical trials for medical research

Blood testing apparatus; Diagnostic apparatus for medical purposes used in medical laboratories for testing how a person metabolizes and responds to medication

Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing of blood; pharmacogenetic testing services, namely, testing of blood to see how a person metabolizes and responds to medication; Blood testing services for testing how a person metabolizes and responds to medication; Genetic testing for medical purposes, namely, genotype analysis

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 22, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 21, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 23, 2026 MAFR
NEW APPLICATION ENTERED
Feb 23, 2026 NWAP